Shi-Bing Su
Impact in
- Pharmacology top 0.5%
- Pharmacological Effects of Natural Compounds
-
- Traditional Chinese Medicine Studies
Papers in
-
- Metabolomics and Mass Spectrometry Studies 11
-
- Traditional Chinese Medicine Studies 24
- Co-authors
- Qilong Chen (26 shared papers)Yi-Yu Lu (39 shared papers)Yoshiharu Motoo (25 shared papers)Qianmei Zhou (22 shared papers)Norio Sawabu (23 shared papers)Min-Jue Xie (19 shared papers)Hui Zhang (18 shared papers)Qing‐Ya Li (4 shared papers)
- Journals
- Evidence-based Complementary and Alternative Medicine (19 papers)Pancreas (9 papers)Digestive Diseases and Sciences (5 papers)Chinese Medicine (4 papers)Acta Pharmacologica Sinica (4 papers)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Shi-Bing Su
121 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 116
- Pharmacology 451
- Complementary and alternative medicine 381
- Hepatology 241
- Cancer Research 276
- Oncology 448
Countries citing papers authored by Shi-Bing Su
This map shows the geographic impact of Shi-Bing Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi-Bing Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi-Bing Su more than expected).
Fields of papers citing papers by Shi-Bing Su
This network shows the impact of papers produced by Shi-Bing Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi-Bing Su. The network helps show where Shi-Bing Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Shi-Bing Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 126 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 253 | |
| 2 | 2009 | 108 | |
| 3 | 2019 | 103 | |
| 4 | 2009 | 82 | |
| 5 | 2015 | 79 | |
| 6 | 2002 | 78 | |
| 7 | Overexpression of p8 is inversely correlated with apoptosis in pancreatic cancer. | 2001 | 75 |
| 8 | Expression of p8 in human pancreatic cancer. | 2001 | 71 |
| 9 | 2018 | 70 | |
| 10 | 2013 | 67 | |
| 11 | 2017 | 66 | |
| 12 | 2014 | 63 | |
| 13 | 2017 | 62 | |
| 14 | 2016 | 61 | |
| 15 | 2021 | 60 | |
| 16 | 2012 | 59 | |
| 17 | 2020 | 58 | |
| 18 | 2019 | 57 | |
| 19 | 2016 | 56 | |
| 20 | 2020 | 48 |
About Shi-Bing Su
Shi-Bing Su is a scholar working on Molecular Biology, Complementary and alternative medicine, Epidemiology, Oncology and Pharmacology, having authored 126 papers that have together received 3.0k indexed citations. Recurring topics across this work include Traditional Chinese Medicine Studies (24 papers), Liver Disease Diagnosis and Treatment (21 papers), Pancreatitis Pathology and Treatment (15 papers), Liver physiology and pathology (12 papers), Pancreatic and Hepatic Oncology Research (12 papers), Metabolomics and Mass Spectrometry Studies (11 papers), Hepatitis B Virus Studies (10 papers) and Pharmacological Effects of Natural Compounds (10 papers). The work is most often cited by research in Pharmacology (451 citations), Complementary and alternative medicine (381 citations), Hepatology (241 citations), Cancer Research (276 citations) and Oncology (448 citations). Shi-Bing Su has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Qilong Chen, Yi-Yu Lu, Yoshiharu Motoo, Qianmei Zhou, Norio Sawabu, Min-Jue Xie, Hui Zhang, Qing‐Ya Li, Yang Sun and Feifei Cai. Their work appears in journals such as Evidence-based Complementary and Alternative Medicine, Pancreas, Digestive Diseases and Sciences, Chinese Medicine and Acta Pharmacologica Sinica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.